Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

KNSA

Kiniksa Pharmaceuticals, Ltd.

Hamilton-based biopharmaceutical firm Kiniksa Pharmaceuticals is dedicated to finding, acquiring, developing and distributing therapeutic drugs aimed at treating patients suffering from debilitatin...

Kiniksa Pharmaceuticals, Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CRVS

Corvus Pharmaceuticals

Corvus Pharmaceuticals, a biopharmaceutical company specializing in clinical stage immuno-oncology therapies, has announced its focus on the development and commercialization of Mupadolimab (CPI-00...

Corvus Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

BCDA

BioCardia, Inc.

California-based BioCardia Inc., a clinical-stage regenerative medicine firm, is in the development stage of creating cellular and cell-derived treatments for pulmonary and cardiovascular diseases....

BioCardia, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

KURA

Kura Oncology

Kura Oncology, Inc. - A Key Player in the Cancer Treatment Industry Kura Oncology, Inc. is a prominent clinical-stage biopharmaceutical company, primarily focused on developing innovative therapie...

Kura Oncology Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

AXLA

Axcella Health

Cambridge-based biotech firm, Axcella Health Inc., has been making waves in the clinical stage biotechnology sector in the U.S. The company's unique approach to treating complex diseases and enhanc...

Axcella Health Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

APLT

Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, based in New York, is blazing a trail in rare disease and diabetic complications research in the United States. The company i...

Applied Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

TLC

Taiwan Liposome Company, Ltd.

Taiwan Liposome Company (TLC) is a clinical-stage pharmaceutical company that specializes in developing and commercializing nanomedicines that use lipid-assembled drug delivery platforms combined w...

Taiwan Liposome Company, Ltd. Annual Report 2019

Healthcare Biotechnology NASDAQ 51-200

IMMP

Immutep Limited

Immutep Limited, a Sydney-based biotechnology company, is advancing cutting-edge research and development efforts in the pharmaceutical industry. With a focus on developing immunotherapeutic produc...

Immutep Limited Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

MBX

Microbix Biosystems Inc.

Microbix Biosystems Inc. is a Canadian company that specializes in the development of biological products and technologies. The company's primary focus is the production of infectious disease antig...

Microbix Biosystems Inc. Annual Report 2023

Healthcare Biotechnology TSX 51-200

IMMU

Mendus

Immunomedics is a biopharmaceutical company that specializes in the development and marketing of monoclonal, antibody-based products for cancer, autoimmune, and other serious diseases. The company ...

Mendus Annual Report 2018

Healthcare Biotechnology NASDAQ 51-200

PSNL

Personalis

Personalis, Inc. is making strides in the cancer genomics industry, providing sequencing and data analysis services globally to support the development of cancer therapies and large-scale genetic r...

Personalis Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

ENTX

Entera Bio Ltd.

Entera Bio Ltd., a Jerusalem-based clinical-stage biopharmaceutical company, is making strides in the development and commercialization of orally delivered large molecule therapeutics for unmet med...

Entera Bio Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CNCE

Concert Pharmaceuticals Inc

Concert Pharmaceuticals is a biopharmaceutical company focused on developing small molecule drugs for a variety of medical conditions, including central nervous system disorders, genetic diseases, ...

Concert Pharmaceuticals Inc Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

ALLK

Allakos Inc.

Allakos Inc., a clinical stage biopharmaceutical company located in San Carlos, California, is making strides in the development of therapeutics that target immunomodulatory receptors on immune eff...

Allakos Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

NC6

Nanollose Limited

Nanollose Limited, a biotechnology company based in Australia, is focused on the development and promotion of microbial nanocellulose technology. Their flagship products include Nullarbor Fibre, a ...

Nanollose Limited Annual Report 2023

Healthcare Biotechnology ASX 1-10